ArticleCureus2026
Effect of Preoperative Hormone Replacement Therapy on Postmenopausal Women Undergoing Rotator Cuff Repair.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The effect of exogenous estrogen, as hormone replacement therapy (HRT), on surgical outcomes following rotator cuff repair (RCR) is unclear. This study evaluated the effect of preoperative HRT on postmenopausal women undergoing RCR. We hypothesize that preoperative HRT use is associated with higher rates of 90-day complications and worse two-year outcomes after RCR. Methodology A retrospective review of 22,992 female patients undergoing RCR in the PearlDiver database was performed. Patients on HRT within one year preoperatively were matched 1:3 with those not on HRT. Overall, 5,748 on HRT and 17,244 not on HRT were included. Univariate and multivariate analyses were performed to compare outcomes between groups. Results After propensity score matching, HRT patients had higher rates of alcohol disorders (p = 0.008), rheumatologic disorders (p = 0.001), and osteoporosis (p = 0.008), as well as an overall increased comorbidity burden, as shown by an increased Charlson Comorbidity Index score (p < 0.001). At two years postoperatively, the HRT group had increased rates of prolonged opioid use (3,958 (68.9%) vs. 10,527 (61.0%); p < 0.001) and total shoulder arthroplasty (123 (2.1%) vs. 296 (1.7%); p = 0.043). After controlling for the remaining differences between groups, the HRT group was still 40% more likely to have prolonged opioid use at two years post RCR (odds ratio: 1.40, 95% confidence interval: 1.31 to 1.49; p < 0.001). When comparing the type of HRT use, those who used oral HRT had increased rates of prolonged opioid use (3,090 (70.1%) vs. 868 (64.7%); p < 0.001) and total shoulder arthroplasty (104 (2.4%) vs. 19 (1.4%); p = 0.048) at two years postoperatively compared to those who used transdermal HRT. Conclusions Based on this study, preoperative HRT appears safe regarding repair integrity, although surgeons could consider risk stratifying patients based on administration route and implementing multimodal pain management strategies for patients on oral therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.